Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy.

The course of the COVID-19 infection has been better understood since the first identification of a novel beta-coronavirus (SARS-CoV-2) in early January 2020 in Wuhan, China [1]. Some individuals w...